NTI drugs have a tiny margin between effective and toxic doses. Learn which common medications like warfarin, lithium, digoxin, and levothyroxine fall into this high-risk category, why switching generics can be dangerous, and how to stay safe with proper monitoring.
View DetailsLithium carbonate generics require careful serum level monitoring due to narrow therapeutic ranges and formulation differences. Even bioequivalent generics can affect blood levels differently, risking toxicity or reduced efficacy in bipolar disorder treatment.
View DetailsGeneric and brand-name drugs contain the same active ingredient, so their risk for drug interactions is identical. Regulatory standards ensure bioequivalence, and real-world data confirms no higher risk with generics.
View DetailsDecision aids help patients understand the real risks and benefits of switching medications, especially when side effects are a concern. They use clear visuals, personal values, and evidence to guide shared decisions with providers.
View DetailsStudies show that switching to generic versions of narrow therapeutic index (NTI) drugs like warfarin, phenytoin, and cyclosporine can lead to dangerous fluctuations in blood levels. While some patients remain stable, others face seizures, organ rejection, or bleeding. Monitoring is critical after any switch.
View DetailsInsurers use preferred generic lists to cut drug costs and lower premiums. These formularies steer patients toward cheaper, equally effective generics - saving billions annually. Learn how they work, where they fall short, and how to navigate them.
View DetailsOrthostatic hypotension is a dangerous side effect of blood pressure meds in older adults. Learn which drugs raise fall risk, which are safest, and how to prevent dizziness without stopping treatment.
View DetailsSome medications lose potency after expiration; others become dangerous. Learn which drugs-like insulin, epinephrine, and liquid antibiotics-you should never use past their expiration date, and why.
View DetailsTentative approval from the FDA lets generic drug makers prepare for market entry before patents expire, but litigation and timing mistakes can cause costly delays. Learn how the Hatch-Waxman Act shapes the race to bring affordable drugs to patients.
View DetailsTrack how your body reacts when switching to generic medications with a simple medication journal. Learn what to record, why it matters, and how to use it to protect your health.
View Details